Safety and Efficacy Study Comparing ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Abnormal Lipid (Fat) Levels in the Blood - Related Studies

Safety and Efficacy Study Comparing ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Abnormal Lipid (Fat) Levels in the Blood

This study is currently recruiting participants.

Study NCT00639158. Last updated on June 26, 2008. Information provided by Abbott

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Dyslipidemias
		Coronary Heart Disease
		Combined (Atherogenic) Dyslipidemia
		Mixed Dyslipidemia

2	Additional conditions recognized in this trial
		Coronary Disease
		Heart Diseases

3	More general conditions related to this trial
		Cardiovascular Diseases
		Lipid Metabolism Disorders
		Metabolic Diseases
		Myocardial Ischemia
		Vascular Diseases

4	Interventions listed in this trial
		ABT-335
		placebo
		atorvastatin
		ezetimibe

5	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Enzyme Inhibitors
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Abbott